Long-term systemic glucocorticoid therapy: Patients' representations, prescribers' perceptions, and treatment adherence

Joint Bone Spine

Volumn 81, Issue 1, 2014, Pages 64-68

  Nassar, Kawtar ^a   Janani, Saadia ^a   Roux, Christian ^b   Rachidi, Wafae ^a   Etaouil, Noufissa ^a   Mkinsi, Ouafaa ^a  

^a IBN ROCHD UNIVERSITY HOSPITAL   (Morocco)

^b Institut Cochin   (France)

Author keywords

Adverse effects; Glucocorticoids; Inflammatory disease; Treatment adherence

Indexed keywords

ANTIDEPRESSANT AGENT; GLUCOCORTICOID;

ABNORMAL BLOOD PRESSURE; ABSENCE OF SIDE EFFECTS; ACNE; ADULT; AMENORRHEA; ARTHRITIS; ARTICLE; ASTHENIA; BODY WEIGHT DISORDER; CATARACT; CORTICOSTEROID THERAPY; DEPRESSION; DIABETES MELLITUS; DROWSINESS; DRUG INDUCED HEADACHE; DRUG SAFETY; DYSLIPIDEMIA; EATING DISORDER; FEMALE; FRACTURE; GLAUCOMA; HEARTBURN; HIRSUTISM; HOSPITAL PHYSICIAN; HUMAN; HYPERHIDROSIS; INSOMNIA; LEG EDEMA; LIPODYSTROPHY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOROCCO; MYOPATHY; OSTEOPOROSIS; PATIENT COMPLIANCE; PATIENT INFORMATION; PERSECUTORY DELUSION; PERSONALITY DISORDER; PRESCRIPTION; PSYCHIATRIC TREATMENT; RECURRENT INFECTION; SKIN BRUISING; STOMACH PAIN; STRIA; SUICIDE ATTEMPT; SYSTEMIC THERAPY; TEACHING HOSPITAL; TREATMENT DURATION; TREMOR; UNSPECIFIED SIDE EFFECT; XEROSTOMIA; CROSS-SECTIONAL STUDY; HEALTH CARE SURVEY; MEDICATION COMPLIANCE; MEDICINE; QUESTIONNAIRE; STATISTICS AND NUMERICAL DATA; ANXIETY DISORDER; CONNECTIVE TISSUE DISEASE; DERMATOMYOSITIS; EATING HABIT; FOLLOW UP; HEADACHE; IRRITABILITY; MEDICAL SPECIALIST; OVERLAP SYNDROME; PHYSICIAN ATTITUDE; RHEUMATOID ARTHRITIS; SARCOIDOSIS; SCLERODERMA; SIDE EFFECT; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULITIS; WEIGHT GAIN;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; GLUCOCORTICOIDS; HEALTH CARE SURVEYS; HOSPITALS, TEACHING; HUMANS; MALE; MEDICATION ADHERENCE; MEDICINE; MIDDLE AGED; SURVEYS AND QUESTIONNAIRES;

EID: 84893727533     PISSN: 1297319X     EISSN: 17787254     Source Type: Journal    
DOI: 10.1016/j.jbspin.2013.07.001     Document Type: Article

References (28)

1. Van Staa T.P., Leufkens H.G., Abenhaim L., et al. Use of oral corticosteroids in the United Kingdom. QJM 2000, 93:105-111.
2. Walsh L.J., Wong C.A., Pringle M., et al. Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study. BMJ 1996, 313:344-346.
3. Fardet L., Kassar A., Cabane J., et al. Corticosteroid-induced adverse events in adults: frequency, screening and prevention. Drug Saf 2007, 30:861-881.
4. Gabriel S.E., Sunku J., Salvarani C., et al. Adverse outcomes of anti-infl{ligature}ammatory therapy among patients with polymyalgia rheumatica. Arthritis Rheum 1997, 40:1873-1878.
5. Fardet L., Flahault A., Kettaneh A., et al. Corticosteroid-induced clinical adverse events: frequency, risk factors and patient's opinion. Br J Dermatol 2007, 157:142-148.
6. Kayani S., Shannon D.C. Adverse behavioral effects of treatment for acute exacerbation of asthma in children: a comparison of two doses of oral steroids. Chest 2002, 122:624-628.
7. Frye C.A., Lacey E.H. The neurosteroids DHEA and DHEAS may infl{ligature}uence cognitive performance by altering affective state. Physiol Behav 1999, 66:85-92.
8. Holsboer F., Grasser A., Friess E., et al. Steroid effects on central neurons and implications for psychiatric and neurological disorders. Ann NY Acad Sci 1994, 746:345-359. [Discussion 359-61].
9. Horne R., Weinman J. Patient's beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 1999, 47:555-567.
10. Reckart M.D., Eisendrath S.J. Exogenous corticosteroid effects on mood and cognition: case presentations. Int J Psychosom 1990, 37:57-61.
11. Ismail K., Wessely S. Psychiatric complications of corticosteroid therapy. Br J Hosp Med 1995, 53:495-499.
12. Fardet L., Blanchon T., Perdoncini-Roux A., et al. Internal medicine physicians' perception of frequency and impact of corticosteroid-induced adverse events. Rev Med Int 2009, 30:113-118.
13. Genereau T., Cabane J. Bénéfl{ligature}ces des corticoïdes dans le traitement de la maladie de Horton et de la pseudopolyarthrite rhizomélique: avantages et inconvénients. Une méta-analyse. Rev Med Int 1992, 13:387-391. [In French].
14. No authors listed Acute adverse reactions to prednisone in relation to dosage. Clin Pharmacol Ther 1972, 13:694-698.
15. Kiraly S.J., Ancill R.J., Dimitrova G. The relationship of endogenous cortisol to psychiatric disorder: a review. Can J Psychiatry 1997, 42:415-420.
16. Morrison E., Crosbie D., Capell A. Attitude of rheumatoid arthritis patients to treatment with oral corticosteroids. Rheumatology 2003, 42:1247-1250.
17. Lambert M., Conus P., Eide P., et al. Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence. Eur Psychiatry 2004, 19:415-422.
18. Sullivan P.S., Campsmith M.L., Nakamura G.V., et al. Patient and regimen characteristics associated with self-reported nonadherence to antiretroviral therapy. PLoS ONE 2007, 2:e552.
19. Byer B., Myers L.B. Psychological correlates of adherence to medication in asthma. Psychol Health Med 2000, 5:389-393.
20. Jessop D.C., Rutter D.R. Adherence to asthma medications: the role of illness representations. Psychol Health 2003, 18:595-612.
21. Harris G.S., Shearer A.G. Beliefs that support the behaviour of people with asthma: a qualitative investigation. J Asthma 2001, 38:427-434.
22. Ohm R., Aaronson L.S. Symptom perception and adherence to asthma controller therapy?. J Nurs Scholarsh 2006, 43:701-704.
23. Charles C., Ninot G., Sultan S. Patients' illness perceptions and adherence to treatment with inhaled corticosteroids in asthma. Rev Mal Respir 2011, 28:626-635. [In French].
24. Tarquinio C., Tarquinio M.P. L'observance thérapeutique: determinations et modèles théoriques. Prat Psychol 2007, 13:1-19. [In French].
25. Leher P., Feldem J., Giardino N., et al. Psychological aspects of asthma. Psychol 2002, 70:691-711.
26. Ulrik C.S., Backer V., Soes-Petersen U., et al. The patient's perspective: adherence or non-adherence to asthma controller therapy?. J Asthma 2006, 43:967-973.
27. Chambers C.V., Markson L., Diamond J.J., et al. Health beliefs and compliance with inhaled corticosteroids by asthmatic patients in primary care practices. Respir Med 1999, 93:88-94.
28. Lewis D.A., Smit R.E. Steroid induced psychiatric syndromes. A report of 14 cases and a review of the literature. J Affect Disord 1983, 5:319-332.